Abhinav Achreja
@abhinavachreja
ID: 251017685
12-02-2011 08:06:53
47 Tweet
52 Followers
132 Following
This is truly a labor of love and strong collaborative effort between Deepak Nagrath Lab Ted Lawrence, Meredith Morgan, Sunitha Nagrath Lab Dr. Edna Cukierman, Ph.D. Anirban Maitra Mara Sherman Lab Jiaqi Shi V Sahai, MD, MS
Much Thanks and grateful to Weiping Han and Russell Ericksen for writing a nice N&V Nature Metabolism for our article nature.com/articles/s4225… on our article rdcu.be/b5r2s U-M Rogel Cancer Center
Lao Tzu "The journey of a thousand miles begins with one step". Attacking stroma may create better treatments for pancreatic cancer PanCAN Monica-Amit Mishra Lustgarten Foundation.New possibilities for a lethal cancer that took away dear friends Michael Steiner and Bharati Vaswani too soon.
Proud to have contributed to this drop in the ocean! Congratulations to Deepak Nagrath Lab Sunitha Nagrath Lab and all our collaborators whose concerted efforts have led to this study.
Here is the Tweetorial of our paper in Nature Metabolism rdcu.be/b5r2s
From the lab of Sunitha Nagrath Lab: "Through its rapid isolation kinetics and adaptability in marker targeting, the EVOD device provides a highly versatile liquid biopsy platform for clinicians to use in the fight against cancer." sciencedirect.com/science/articl…
A timely review of metabolic plasticity in radiotherapy treated cancers and emergence of radioresistance by Deepak Nagrath Lab. Radiotherapy-induced metabolic hallmarks in the tumor microenvironment sciencedirect.com/science/articl…
We are thrilled to present the new study from our lab. We uncover #MTHFD2 as a collateral lethal gene target in #ovariancancer. We found a MTHFD2 driven noncanonical #NAD flux in #ETC suppressed cancers. Nature Metabolism U-M Rogel Cancer Center U-M BME @NCICancerBio nature.com/articles/s4225…
University of Michigan and IU School of Medicine scientists have developed a new method called CLIM that identifies #collateral #lethal genes in #cancers. These can be targeted for better treatments. genengnews.com/topics/cancer/…
Therapeutic implications of mitochondrial stress–induced proteasome inhibitor resistance in multiple myeloma | Science Advances; Excited to share our new story lead by my amazing postdoc Aditi Sharma in collaboration with Deepak Nagrath Lab science.org/doi/10.1126/sc…
RESEARCH | Deepak Nagrath Lab, Abhinav Achreja et al. (U-M BME, Michigan Chemical Engineering, U-M Rogel Cancer Center) develop a framework to identify collateral lethalities in cancer, uncovering MTHFD2 as a collateral lethal gene in UQCR11-deficient ovarian tumors. #CancerResearch nature.com/articles/s4225…
Jim Lynch FierceBiotech GEN Congrats to Abhinav Achreja and Deepak Nagrath Lab on a great result! Here's Jim's story: news.engin.umich.edu/2022/09/shutti…
Ecstatic to be featured in FierceBiotech: Leveraging machine learning to hone precision meds targeting cancer backup genes fiercebiotech.com/research/preci… Deepak Nagrath Lab
Excited to be presenting my work at Keystone Symposia #KSBIOENERGETICS23 #KSAdipose23. Please be sure to check out my talk (Workshop 2) on 1/18/23 at 2.30pm MST
Another week, another chance to highlight #UMPrecisionHealth member activities & accomplishments! bit.ly/3khAXvb Ft highlights from Mark Bicket, MD, PhD, FASA Preeti Malani Salim S. Hayek, MD Abhinav Achreja Maria Papaleontiou, MD and David Blaauw
Another great study from the Deepak Nagrath Lab and Daniel Wahl labs being presented TODAY by the talented grad student @AnjaliM69502453 (Poster J4-2013) at Keystone Symposia #Ksbioenergetics23 #KSAdipose23. Please check it out!